We are live on ! Find out more
EA

Emerald Acquisition Portfolio holdings

AUM $51.8B
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$57.7B
AUM Growth
Cap. Flow
+$57.1B
Cap. Flow %
98.97%
Top 10 Hldgs %
10.09%
Holding
2,993
New
2,993
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$755M
2
MSFT icon
Microsoft
MSFT
+$711M
3
WFC icon
Wells Fargo
WFC
+$630M
4
TSM icon
TSMC
TSM
+$575M
5
JPM icon
JPMorgan Chase
JPM
+$549M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 17.76%
2 Healthcare 12.74%
3 Technology 11.3%
4 Industrials 10.13%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COWN
2576
DELISTED
Cowen Inc. Class A Common Stock
COWN
$310K ﹤0.01%
+26,193
New +$357K
CRVS icon
2577
Corvus Pharmaceuticals
CRVS
$1.16B
$308K ﹤0.01%
+21,615
New +$292K
DXYN
2578
DELISTED
Dixie Group Inc
DXYN
$305K ﹤0.01%
+85,800
New +$331K
LTM
2579
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$303K ﹤0.01%
+45,980
New +$304K
BLDR icon
2580
Builders FirstSource
BLDR
$7.53B
$302K ﹤0.01%
+26,842
New +$310K
TKR icon
2581
Timken Company
TKR
$9.84B
$299K ﹤0.01%
+9,758
New +$327K
ODC icon
2582
Oil-Dri
ODC
$1.37B
$295K ﹤0.01%
+17,068
New +$285K
OLP
2583
One Liberty Properties
OLP
$545M
$294K ﹤0.01%
+12,326
New +$284K
IMDZ
2584
DELISTED
Immune Design Corp.
IMDZ
$292K ﹤0.01%
+35,867
New +$447K
RENX
2585
DELISTED
RELX N.V.
RENX
$292K ﹤0.01%
+16,752
New +$286K
AKBA icon
2586
Akebia Therapeutics
AKBA
$327M
$289K ﹤0.01%
+38,666
New +$338K
BELFB
2587
Bel Fuse Inc Class B
BELFB
$4.05B
$288K ﹤0.01%
+16,187
New +$274K
LYTS icon
2588
LSI Industries
LYTS
$866M
$288K ﹤0.01%
+25,998
New +$309K
TCRT icon
2589
Alaunos Therapeutics
TCRT
$4.66M
$286K ﹤0.01%
+348
New +$379K
WEX icon
2590
WEX
WEX
$5.91B
$286K ﹤0.01%
+3,226
New +$288K
UNTD
2591
DELISTED
UNITED ONLINE INC COM NEW
UNTD
$286K ﹤0.01%
+25,964
New +$286K
MCHX icon
2592
Marchex
MCHX
$78M
$283K ﹤0.01%
+88,858
New +$334K
DEG
2593
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
$282K ﹤0.01%
+10,747
New +$280K
RBC icon
2594
RBC Bearings
RBC
$18.9B
$281K ﹤0.01%
+3,874
New +$284K
PGNX
2595
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$278K ﹤0.01%
+65,928
New +$318K
PRTY
2596
DELISTED
Party City Holdco Inc.
PRTY
$277K ﹤0.01%
+19,942
New +$275K
ORIT
2597
DELISTED
Oritani Financial Corp. New
ORIT
$275K ﹤0.01%
+17,195
New +$286K
CETV
2598
DELISTED
Central European Media Enterprises Ltd
CETV
$272K ﹤0.01%
+128,820
New +$320K
DGI
2599
DELISTED
DigitalGlobe Inc.
DGI
$271K ﹤0.01%
+12,695
New +$256K
BAH icon
2600
Booz Allen Hamilton
BAH
$7.91B
$270K ﹤0.01%
+9,086
New +$260K

Similar funds

Emerald Acquisition's Q2 2016 Portfolio in Review

Q2 2016 is the first quarter with a 13F filing on record for Emerald Acquisition, which disclosed 2,993 positions worth $57.7B. Its ten largest holdings account for 10% of the portfolio.

Its largest position is Johnson & Johnson: 6,642,592 shares worth $805M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, followed by Healthcare and Technology.

  • Emerald Acquisition's largest Q2 2016 buy was Johnson & Johnson: 6,642,592 shares worth $805M.
  • Emerald Acquisition's ten largest holdings make up 10% of its $57.7B portfolio in Q2 2016.
  • Emerald Acquisition disclosed 2,993 positions in Q2 2016, its first 13F filing on record.

Based on Emerald Acquisition's 13F filing for Q2 2016, filed 3 Aug 2016.